What caused the TLIK.F stock jump on 03 Feb 2026?

The jump to **€0.262** was driven by thin liquidity and speculative buying. Volume was **18** shares, far below average. No scheduled earnings were released, so the move reflects small-order flows and sector chatter rather than confirmed operational news.

How does Meyka AI view TLIK.F stock?

Meyka AI rates TLIK.F with a score out of 100: **58.78 (C+, HOLD)**. The grade weighs benchmark and sector comparison, key metrics and forecasts. This is informational and not investment advice.

What is the short-term forecast for TLIK.F stock?

Meyka AI's forecast model projects a monthly price of **€0.27**, implying **~3.05%** upside from the current **€0.262**. Forecasts are model-based projections and not guarantees.

Are there clear valuation risks for TLIK.F stock?

Yes. Key risks include negative EPS **-€0.11**, negative cash flow per share and a low current ratio **0.04**. These metrics point to liquidity and operational risks versus sector peers.

DE Stocks

TLIK.F up 19.09% on XETRA 03 Feb 2026: thin-volume rally on cautionary fundamentals

ByDanny Kontos February 3, 2026

The TLIK.F stock surged 19.09% on XETRA on 03 Feb 2026, closing at €0.262 after opening at the same level. The jump came on very low volume of 18 shares versus a 50-day average of 368, signalling a thin-volume move rather than broad buying. Traders reacted to company-level updates and healthcare sector modest gains, but core financials remain weak. We summarise the price action, valuation, Meyka AI grading and a short-term forecast to help investors judge risk and opportunity in this Germany-listed Healthcare distributor.